Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography Results in Negative Surgical Margins and Decreased Local Recurrence in an Orthotopic Mouse Model of Osteosarcoma.

Tytuł:
Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography Results in Negative Surgical Margins and Decreased Local Recurrence in an Orthotopic Mouse Model of Osteosarcoma.
Autorzy:
Mahjoub A; School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Morales-Restrepo A; Musculoskeletal Oncology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Fourman MS; Musculoskeletal Oncology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Mandell JB; Musculoskeletal Oncology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Feiqi L; Musculoskeletal Oncology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.; School of Medicine, Tsinghua University, Beijing, China.
Hankins ML; Musculoskeletal Oncology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Watters RJ; Musculoskeletal Oncology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
Weiss KR; Musculoskeletal Oncology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA. .
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2019 Mar; Vol. 26 (3), pp. 894-898. Date of Electronic Publication: 2018 Dec 27.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: 2005- : New York, NY : Springer
Original Publication: New York, NY : Raven Press, c1994-
MeSH Terms:
Fluorescence*
Bone Neoplasms/*surgery
Fluorescein Angiography/*methods
Neoplasm Recurrence, Local/*prevention & control
Optical Imaging/*methods
Osteosarcoma/*surgery
Surgery, Computer-Assisted/*methods
Animals ; Bone Neoplasms/diagnostic imaging ; Bone Neoplasms/pathology ; Female ; Fluorescent Dyes ; Indocyanine Green/metabolism ; Intraoperative Care ; Margins of Excision ; Mice ; Mice, Inbred BALB C ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Osteosarcoma/diagnostic imaging ; Osteosarcoma/pathology
References:
J Clin Oncol. 2005 Jan 1;23(1):96-104. (PMID: 15625364)
Acta Orthop. 2008 Oct;79(5):695-702. (PMID: 18839378)
PLoS One. 2011;6(8):e20294. (PMID: 21826194)
Br J Cancer. 2014 Mar 18;110(6):1456-64. (PMID: 24481401)
Ann Surg Oncol. 2014 Jun;21(6):1948-55. (PMID: 24558066)
Acta Orthop. 2014 Jun;85(3):323-32. (PMID: 24694277)
ANZ J Surg. 2014 Jul-Aug;84(7-8):533-8. (PMID: 24712375)
Cancer. 2014 Sep 15;120(18):2866-75. (PMID: 24894656)
Clin Orthop Relat Res. 2014 Oct;472(10):3188-95. (PMID: 24980644)
Burns. 2015 Aug;41(5):1043-8. (PMID: 25499407)
Orthop Traumatol Surg Res. 2015 Feb;101(1):103-7. (PMID: 25583234)
PLoS One. 2015 Apr 07;10(4):e0122216. (PMID: 25849226)
Ann Surg. 2016 Mar;263(3):593-600. (PMID: 25915910)
Clin Orthop Relat Res. 2016 Mar;474(3):677-83. (PMID: 26013153)
Radiat Oncol. 2016 Feb 25;11:25. (PMID: 26911328)
Cancer Med. 2016 Jun;5(6):980-8. (PMID: 26929181)
Clin Orthop Relat Res. 2017 Mar;475(3):842-850. (PMID: 27138473)
Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):119-26. (PMID: 27319287)
Iowa Orthop J. 2016;36:98-103. (PMID: 27528844)
Ann Oncol. 2016 Dec;27(12):2283-2288. (PMID: 27733375)
Int J Surg Oncol. 2016;2016:5963167. (PMID: 27803813)
BMJ Open. 2017 Feb 14;7(2):e012930. (PMID: 28196946)
Orthop Traumatol Surg Res. 2018 Feb;104(1S):S9-S17. (PMID: 29203433)
Surg Innov. 2018 Feb;25(1):62-68. (PMID: 29303061)
Clin Orthop Relat Res. 2018 Mar;476(3):479-487. (PMID: 29408832)
BMC Cancer. 2018 Mar 20;18(1):304. (PMID: 29558901)
Oncotarget. 2018 Jul 10;9(53):30163-30172. (PMID: 30046395)
Iowa Orthop J. 2018;38:123-130. (PMID: 30104934)
Grant Information:
K08 CA177927 United States CA NCI NIH HHS
Substance Nomenclature:
0 (Fluorescent Dyes)
IX6J1063HV (Indocyanine Green)
Entry Date(s):
Date Created: 20181228 Date Completed: 20190528 Latest Revision: 20200225
Update Code:
20240105
PubMed Central ID:
PMC6373227
DOI:
10.1245/s10434-018-07114-9
PMID:
30588559
Czasopismo naukowe
Background: Surgical resection with negative margins is the foundation of extremity sarcoma management. Failure to achieve negative surgical margins can result in local recurrence (LR), a potentially devastating complication. Indocyanine green (ICG) is a US FDA-approved fluorophore previously used to guide carcinoma resections. We investigated the potential of ICG as an intraoperative guide during experimental sarcoma resection.
Methods: Fifty 6-week-old immunocompetent Balb/c female mice received left proximal tibia paraphyseal injections of 5 × 10 5 K7M2 murine osteosarcoma cells. Animals were separated into two groups (n = 25 each): (1) ICG-assisted surgical resection; and (2) no ICG-assisted resection. Resections were performed 4 weeks after primary tumor engraftment. All animals received 7.5 ug ICG via retro-orbital injection 12 h prior to surgery. ICG fluorescence measurements and clinical evaluations were performed 4 weeks after resection to detect LR.
Results: Eleven of 25 animals from each group developed gross tumors. Four weeks after resection, group 1 had 0/11 tumor recurrences, while group 2 had recurrences in 9/11 (81.8%) experimental mice (p < 0.0002) (Fig. 2). There was a 100% NPV in group 1, and no tumor recurrence with fluorescence-free margins after the primary surgery. Group 2 had a 100% positive predictive value for the development of an LR if any fluorescent signal was present at the surgical margin after resection.
Conclusion: Intraoperative ICG guidance led to reliably negative surgical margins and a diminished LR rate. Given the benign safety profile of ICG and its prior clinical success, these results could be immediately translatable to the clinical realm.
Comment in: Ann Surg Oncol. 2019 Dec;26(Suppl 3):628-629. (PMID: 31187368)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies